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Abstract 
Purpose: To investigate the effect and mechanism of action of Ermiao san (EMS), a traditional Chinese 
herbal formula, on inflammation development and production of inflammatory mediators in adjuvant-
induced arthritis (AIA).  
Methods: AIA was induced by injection of 0.1 ml Freund’s complete adjuvant (FCA, 10 mg/ml) in the 
left hind footpad of the rats. AIA rats were intragastricly treated with 0.5, 1, 2 g/kg EMS or 0.1 g/kg 
methotrexate from day 7 to 28 after FCA challenge. Foot volume and histological score were measured. 
Osteoclast number was calculated by tartrate-resistant acid phosphatase (TRAP) staining assay. Levels 
of prostaglandin (PG) E2, tumor necrosis factor (TNF) -α and interleukin (IL)-1β in serum were 
determined by enzyme-linked immunosorbent assay (ELISA) while the level of nitric oxide (NO) in 
serum was analyzed by Griess reaction method. 
Results: Foot volume, histological score, osteoclast number and serum levels of TNF-α, IL-1β, PGE2 
and NO were all increased in AIA group rats on day 28 after FCA challenge (all p < 0.01) compared with 
control. EMS (1 and 2 g/kg) significantly decreased the foot volume of AIA rats by 10 % (p < 0.05) and 
19 % (p < 0.01), respectively, compared with AIA group. Furthermore, 1 and 2 g/kg EMS significantly 
reduced histological score by about 28 % (p < 0.05) and 46 % (p < 0.01), respectively, as well as 
osteoclast number by 12 % (p < 0.05) and 15 % (p < 0.05), respectively, compared with AIA group. In 
addition, 1 and 2 g/kg EMS significantly decreased the serum levels of TNF-α about 23 % (p < 0.05) 
and 43 % (p < 0.01), IL-1β by15 % (p < 0.05) and 26 % (p < 0.01), NO 13 % (p < 0.05) and 26 % (p < 
0.01) as well as PGE2 by 11 % (p < 0.05) and 15 % (p < 0.01), respectively, compared with AIA group. 
Conclusion: These results suggest that EMS probably alleviates arthritis development and joint 
destruction by decreasing the production of inflammatory mediators in AIA rats. 
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Rheumatoid arthritis (RA) is an autoimmune 
disease characterized by chronic inflammation 
with the lesions of cartilage and bone, and finally 
results in joint destruction and deformity [1]. 
Inflammatory mediators such as interleukin (IL)-
1β, tumor necrosis factor (TNF)-α, prostaglandin 
E2 (PGE2) and nitric oxide (NO) play a key role in 
the pathogenesis of RA [2-4]. Antigen-presenting 
cells, including dendritic cells, macrophages and 
B cells, present RA-associated antigens to T 
cells [5]. Simultaneously, antigen-activated CD4+ 
T cells amplify the immune response by 
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activating multiple types of cells including 
synovial fibroblasts, T cells, B cells, monocytes, 
macrophages, chondrocytes and osteoclasts [6]. 
These activated cells can produce a variety of 
inflammatory mediators which contribute to the 
synovitis development. Concurrently, 
inflammatory mediators may stimulate 
inflammatory cells to produce more inflammatory 
mediators, as well as matrix metalloproteinases, 
aggrecanases and collagenases which contribute 
to the destruction of cartilage and bone [7]. 
 
In current clinical practice, non-steroidal anti-
inflammatory drugs, corticosteroids, disease-
modifying anti-rheumatic drugs and biologic 
agents are the main anti-rheumatic drugs applied 
for RA treatment [8]. However, severe adverse 
and toxic effects, expensive costs and limited 
efficacy spur RA patients on to natural herbal 
therapies including traditional Chinese medicine 
(TCM) for its effectiveness and hypotoxicity in 
recent years [9]. 
 
Ermiao san (EMS) is a traditional Chinese herbal 
formula which is composed of Atractylodes 
chinensis (DC.) Koidz. and Phellodendron 
chinensis Schneid. (Rutaceae). in a weight ratio 
of 1:1. EMS has been empirically used to treat 
“Bi Zheng” for hundreds of years, and in current 
clinic of TCM, EMS and its modified formulae are 
frequently used for treatment of RA [10]. 
Documents have demonstrated the 
pharmacological activities of EMS. EMS showed 
a remarkable improvement against the elevation 
in serum transaminase levels as well as in 
histopathological changes of immunological liver 
injury in mice [11]. Chinese herbal formulas Si-
Wu-Tang and EMS synergistically ameliorated 
hyperuricemia and renal impairment in rats [12]. 
However, up till now, the effect and potential 
mechanisms of EMS on adjuvant-induced 
arthritis (AIA) in rats are not totally understood. 
Therefore, in the present study, we investigated 
the effect of EMS on the arthritis development 
and production of inflammatory mediators in AIA 




Preparation of EMS extract 
 
Atractylodes chinensis (DC.) Koidz. and 
Phellodendron chinensis Schneid. (Rutaceae) 
were purchased from Chongqing Tongjunge 
Pharmacy (Chongqing, China) and were 
identified by Dr. Jifen Zhang, College of 
Pharmaceutical Sciences, Southwest University 
(Chongqing, China). Morphological, microscopic 
authentications and thin layer chromatography 
were performed in accordance to Chinese 
Pharmacopoeia (2010). Herbarium voucher 
specimens of the tested herbs were deposited at 
the Chongqing Key Laboratory of Nature 
Medicine Research, Chongqing Technology and 
Business University, with voucher specimen 
numbers as follows: 2013-109 (Atractylodes 
chinensis (DC.) Koidz.) and 2013-187 
(Phellodendron chinensis Schneid. (Rutaceae)). 
Raw herbal materials (500 g:500 g) were 
extracted with boiling water (1:8, w / v) for 1 h 
and the extraction was repeated twice. The 
solution was filtered and concentrated and then 
made into freeze-dried powder. 268 g EMS 
freeze-dried extract powder was obtained from 
1000 g raw material (the yield was 26.8 %). The 
freeze-dried powder was stored at -70 °C until 
use. 
 
Drugs and chemicals  
 
All chemicals and reagents were purchased from 
Sigma-Aldrich (USA) unless otherwise specified. 
Enzyme-linked immunosorbent assay (ELISA) 
kits for TNF-α, IL-1β and PGE2 were purchased 
from Pierce (USA). Bacillus Calmette-Guerin 
(BCG) was purchased from Shanghai 
biochemical factory (China). Methotrexate (MTX) 
was purchased from Shanghai Xinyi 
pharmaceutical factory (China). Tartrate-resistant 
acid phosphatase (TRAP) kit was purchased 
from Sigma.  
 
Induction of AIA 
 
Male Sprague-Dawley rats weighing 200-220 g 
were purchased from the Third Military Medical 
University (China). All rats were housed in a 
temperature-controlled room (22 ± 2 °C) under a 
light/dark cycle with lights on from 7:00 am to 
7:00 pm. They were allowed food and water ad 
libitum. All animal procedures were approved by 
the Ethical Committee in Animal Research of 
Chongqing Technology and Business University 
(ref no. 2013-7-12/CTBU). Freund’s complete 
adjuvant (FCA) was prepared by suspending 
heat-killed BCG in sterile mineral oil (10 mg/ml). 
Arthritis was induced by a single injection of 100 
μl of FCA intradermally in the left hind footpad of 




Rats were randomly divided into six groups with 
8 rats in each group: (1) Control group, (2) AIA 
group, (3) 0.1 mg/kg MTX group, (4) 0.5 g/kg 
EMS group, (5) 1 g/kg EMS group, (6) 2 g/kg 
EMS group. According to the clinical practice of 
TCM, the dosage of EMS for adults (60 
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kg/person) is 30 g/60 kg/d, equivalently, for rats, 
this dosage is 3 g/kg/d calculated by the formula 
that converts dosage of human into that of rats 
according to the respective body surface areas.  
 
In the present study, the yield of EMS water 
extract was 26.8 %, making the dosage of XTW 
extract about 1 g/kg/d. Arthritic rats of (3), (4), (5) 
and (6) groups were intragastricly treated with 
MTX or EMS once a day. For the Control and 
AIA groups, rats were intragastricly treated with 2 
ml physiological saline. All the rats received 
treatment from day 7 to day 28 after FCA 
immunization. 
 
Assessment of foot volume  
 
From day 7 to day 28 following FCA challenge, 
foot volume of the left hind of all the rats was 
measured by PBC7140 plethysmometer (Ugo 
Basile, Italy) every 7 days [14]. The 
measurement was carried on by one investigator 
blind to the experimental protocol. 
 
Assessment of histological score  
 
All rats were sacrificed 1 h after the last drug 
treatment. The left ankle joints were surgically 
removed, fixed in 4 % paraformaldehyde for 48 
h, decalcified in 10 % ethylene diamine 
tetraacetic acid for 28 days, then embedded in 
paraffin. Serial paraffin sections (6 μm) were 
stained with hematoxylin and eosin (H&E). 
Histopathological changes in joint were scored 
(histological score) using the following 
parameters by one investigator blind to the 
experimental protocol [15]: 0: normal, 1: 
infiltration of inflammatory cells, 2: synovial 
hyperplasia, 3: pannus formation, 4: bone 
erosion, 5: bone destruction.  
 
Assessment of osteoclast number 
 
Serial paraffin sections were prepared as 
previously described in the section of 
“Assessments of histological score”. TRAP 
staining was carried on according to the 
manufacturer’s instructions. Briefly, tissue 
sections were dewaxed in xylene and rehydrated 
in graded ethanol. After washing with distilled 
water, sections were incubated in the reaction 
mixture at 37 °C in a humid and light-protected 
incubator for 1 h. Thereafter, sections were 
washed three times with distilled water, 
counterstained with hematoxylin, and observed 
under a microscope. The number of osteoclasts 
(TRAP-positive cells) was calculated at high 
magnification (× 100). The results are expressed 
as the total number of osteoclasts per slide [16]. 
 
Analysis of inflammatory mediators  
 
Blood was obtained by cardiac puncture under 
ether anesthesia prior to sacrifice. Serum was 
obtained from coagulated blood by centrifuge at 
4000 g for 20 min. Serum samples were stored 
at -20 °C until use. Levels of TNF-α, IL-1β and 
PGE2 in serum were tested using enzyme-linked 
immunosorbent kits. Level of NO in serum was 
determined with a NO test kit based on the 
Griess reaction method. Assays were performed 




All data were presented as means ± standard 
error (SD). Statistical comparisons were 
evaluated by ANOVA test using SPSS 16 
software. Differences between values were 




Effect of EMS on foot volume of AIA rats  
 
Arthritis had developed in the immunized rats on 
the 3rd day after FCA challenge. Joint swelling 
and erythema were observed as obvious signs of 
the evolution of arthritis. There was no significant 
difference in the arthritis amongst all the groups 
(two groups of AIA, MTX and three doses of 
EMS groups) on day 7. However, following 
treatment, compared with the control group, foot 
volume of rats in AIA group was markedly 
enlarged on day 28 (p < 0.01, Figure 1). On 
treatment with 1 and 2 g/kg EMS for 21 days, 
foot volume of arthritic rats were significantly 
decreased compared with AIA group given saline 
(p < 0.05 and p < 0.01 respectively, Figure 1). 
However, treatment with 0.5 g/kg EMS for 21 
days did not statistically reduce the foot volume 
(Figure 1). Treatment with 0.1 mg/kg MTX for 21 
days remarkably decreased the foot volume 
compared with AIA group (p < 0.01, Figure 1). 
 
Effect of EMS on histological score of AIA 
rats 
 
Histological score represents the degree of 
severity of articular inflammation and destruction. 
Compared with Control group, histological score 
of AIA group was markedly increased on day 28 
(p < 0.01, Figure 2). Treatment with 1 and 2 g/kg 
EMS significantly reduced the histological score 
compared with AIA group in a dose-dependent 
manner (p < 0.05 and p < 0.01 respectively, 
Figure 2). 0.1 mg/kg MTX also markedly 
decreased the histological score (p < 0.01, 
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Figure 2). However, 0.5 g/kg EMS did not 
statistically reduced the histological score 
compared with AIA group. 
 
 
Figure 1: Effect of EMS on foot volume of AIA rats 
during treatment. AIA rats were treated with EMS, 
MTX or saline for 21 days. Foot volume was measured 
every 7 days during treatment. Data are expressed as 
mean ± SD (n=8). $p < 0.01 compared with Control 
group; #p < 0.05, ##p < 0.01 compared with AIA group 
 
 
Figure 2: Effect of EMS on histological score of AIA 
rats. AIA rats were treated with EMS, MTX or saline 
for 21 days. Data are expressed as mean ± SD (n = 
8). #p < 0.05, ##p < 0.01 compared with AIA group 
 
Effect of EMS on osteoclast number of AIA 
rats 
 
To evaluate the effect of EMS on osteoclast 
number, joint sections were stained with TRAP. 
A significant increase of osteoclast number was 
observed in AIA group compared with the Control 
group (p < 0.01, Figure 3). Treatment with 1 and 
2 g/kg EMS significantly reduced the osteoclast 
number compared with AIA group (both p < 0.05, 
Figure 3). Meanwhile, 0.1 mg/kg MTX also 
markedly decreased the osteoclast number 
compared with AIA group (p < 0.01, Figure 3). 
However, a statistical reduction of osteoclast 
number was not observed in 0.5 g/kg EMS group 
compared with AIA group. 
 
 
Figure 3: Effect of EMS on osteoclast number of AIA 
rats. AIA rats were treated with EMS, MTX or saline 
for 21 days. Data are expressed as mean ± SD (n = 
8). $p < 0.01 compared with Control group; #p < 0.05, 
##p < 0.01 compared with AIA group 
 
Effects of EMS on levels of inflammatory 
mediators in serum of AIA rats 
 
The levels of TNF-α, IL-1β, PGE2 and NO in 
serum were all significantly elevated in AIA group 
rats than in Control group rats (p < 0.01, Figure 
4). Treatment with 1 and 2 g/kg EMS markedly 
decreased the serum levels of TNF-α, IL-1β, 
PGE2 and NO compared with Control group in a 
dose-dependent manner (p < 0.05 and p < 0.01 
respectively, Figure 4). Meanwhile, 0.1 mg/kg 
MTX significantly decreased the serum levels of 
TNF-α, IL-1β, PGE2 and NO compared with AIA 
group rats (p < 0.01, Figure 4).However, 0.5 g/kg 
EMS did not statistically reduced the serum 
levels of TNF-α, IL-1β, PGE2 and NO compared 




In this study, we demonstrated that EMS, a 
traditional Chinese herbal formula, significantly 
decreased the foot volume, histological score 
and osteoclast number in arthritic tissues of 
adjuvant-induced arthritis (AIA) rats. 
Simultaneously, treatment with EMS significantly 
reduced the levels of TNF-α, IL-1β, PGE2 and 
NO in serum of AIA rats. 
 
It is well-known fact that redness, swelling, heat 
and pain are the main characteristics of 
inflammation [13]. In AIA, a classic animal model 
of human rheumatoid arthritis (RA), foot volume 
is verified to be closely related to arthritis 
development. Currently, foot volume is one of the 
most frequent-used indices to measure the anti-
arthritic effect of tested drugs [17]. 
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Figure 4: Effect of EMS on levels of TNF-α, IL-1β, NO and PGE2 in serum of AIA rats. AIA rats were treated with 
EMS, MTX or saline for 21 days. Data are expressed as mean ± SD (n = 8). $p < 0.01 compared with Control 
group; #p < 0.05, ##p < 0.01 compared with AIA group 
 
In this study, foot volume was markedly 
increased after intradermal injection of FCA for 
28 days in rats. After treatment with EMS for 21 
days, foot volume of AIA rats were significantly 
reduced in a dose-dependent manner. At the 
same time, we also found that both erythralgia 
and dysfunction in EMS-treated AIA rats were 
clearly alleviated. These results suggested that 
EMS might significantly attenuate the 
inflammatory development of AIA in rats. 
 
It is reported that RA is the leading cause of 
disability in the world due to the progressive 
erosion of cartilage and bone. Numerous 
evidences suggest that joint destruction in RA is 
mainly due to chronic inflammation [18]. In RA, 
the synovial tissue undergoes hypertrophy via 
proliferation of the synovial cells and homing of 
monocytes and fibroblasts, and the result is 
development of the rheumatoid pannus [19]. 
Rheumatoid pannus is considered as the 
hallmark of chronic inflammation and mediates 
cartilage damage in RA. Many inflammatory 
mediators such as IL-1β and TNF-α, can activate 
the osteoclasts [20]. The abundant activated 
osteoclasts that are characteristic of rheumatoid 
inflammation directly destroy bone [21]. 
Histological score and osteoclast number are two 
frequently-used index which represent the 
degree of severity of articular inflammation and 
destruction. In this study, the histological score 
and osteoclast number were significantly 
increased in AIA rats which indicated the serious 
joint destruction induced by FCA in the rats. 
However, treatment with EMS dose-dependently 
reduced the histological score and osteoclast 
number, which suggested that EMS might 
significantly alleviate the joint destruction in AIA 
rats.  
 
A great number of clinical and experimental data 
support the pivotal role of TNF-α, IL-1β, PGE2 
and NO in the pathogenesis of RA. TNF-α 
promotes bone resorption directly through 
activation of cells of the osteoclasts [22], and 
indirectly through the expression of osteoclast 
activators [23]. TNF-α also suppresses bone 
formation via increased osteoblast apoptosis 
[24], and reduced differentiation and proliferation 
of osteoblasts and their progenitors [25]. IL-1β 
reduces chondrocyte proteoglycan synthesis 
[26], increases the synthesis of matrix 
metalloproteinases and the release of nitric oxide 
[27]. Transgenic mice deficient in IL-1 receptor 
antagonist spontaneously develop a chronic 
arthritis similar to RA with bone erosions and 
present higher susceptibility for collagen-induced 
arthritis [28]. Other studies show that IL-1β is not 
predominant in the acute inflammatory stages of 
most experimental arthritis models, but plays a 
significant role in perpetuating joint inflammation 
and in the pathogenesis of bone and cartilage 
damage [29]. NO contributes to T cell activation 
in RA by altering multiple signaling pathways in T 
cells [30]. NO produced in the inflammatory joint 
may contribute to the peri-articular bone-loss 
observed in RA. Transgenic mice deficient in NO 
production are resistant to IL-1-induced bone 
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resorption [31]. PGE2 is considered to be the 
major contributor to inflammatory pain in RA. 
PGE2 and NO also promote inflammation 
development and participate in destructive 
mechanisms in the rheumatoid joint [32]. These 
evidences highlight the key role of TNF-α, IL-1β, 
PGE2 and NO in the inflammation development 
and bone and cartilage damage in RA. In this 
study, levels of TNF-α, IL-1β, PGE2 and NO in 
serum of AIA rats were all significantly elevated, 
which suggested the important role of these 
inflammatory mediators in the pathogenesis of 
AIA in rats. Treatment with EMS significantly 
lowered the levels of TNF-α, IL-1β, PGE2 and 
NO in serum of AIA rats, although the degree of 
reduction were lower than methotrexate, the 
positive controlled drug used in this study. These 
findings suggest that the ameliorative effect of 
EMS on foot volume and joint destruction may be 
closely related to the reduction of production of 




The findings of the study indicate that EMS 
suppresses inflammation development and joint 
destruction in AIA rats, and that the potential 
mechanism may be closely associated with 
inhibition of the production of inflammatory 
mediators including TNF-α, IL-1β, PGE2 and NO. 
These data provide mechanistic evidence for 
anti-arthritic application of EMS in TCM and also 
suggest that EMS is a promising candidate for 
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